Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about METABOLISM: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | METABOLISM |
| Key Genes/Proteins | RUBCN/Rubicon |
| Related Diseases | FERROPTOSIS |
| Related Pathways | EPIGENOME, PI3K_AKT_MTOR |
Knowledge base pages for this entity
graph TD
METABOLISM["METABOLISM"]
METABOLISM -->|"modulates"| Cell_Death["Cell Death"]
METABOLISM -->|"contributes to"| Alzheimer_s_Disease["Alzheimer's Disease"]
METABOLISM -->|"involved_in"| Retinal_Ganglion_Cell["Retinal Ganglion Cell"]
METABOLISM -->|"regulates"| Alzheimer_s_disease["Alzheimer's disease"]
METABOLISM -->|"regulates"| FERROPTOSIS["FERROPTOSIS"]
METABOLISM -->|"regulates"| EPIGENOME["EPIGENOME"]
Glycolipids["Glycolipids"] -->|"regulates"| METABOLISM
MTOR["MTOR"] -->|"regulates"| METABOLISM
mTOR["mTOR"] -->|"regulates"| METABOLISM
SIRT1["SIRT1"] -->|"regulates"| METABOLISM
AMPK["AMPK"] -->|"regulates"| METABOLISM
Ampk["Ampk"] -->|"regulates"| METABOLISM
Sex_Hormones["Sex Hormones"] -->|"regulates"| METABOLISM
Mitochondrial_Derived_Vesicles["Mitochondrial-Derived Vesicles"] -->|"regulates"| METABOLISM| Target | Relation | Type | Str |
|---|---|---|---|
| Cell Death | modulates | process | 0.88 |
| Alzheimer's Disease | contributes_to | disease | 0.85 |
| Schizophrenia | contributes_to | disease | 0.75 |
| Retinal Ganglion Cell | involved_in | cell_type | 0.75 |
| Cardiovascular Disease | associated_with | disease | 0.70 |
| Alzheimer's disease | regulates | disease | 0.70 |
| FERROPTOSIS | regulates | phenotype | 0.64 |
| EPIGENOME | regulates | pathway | 0.56 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Glycolipids | regulates | compound | 0.95 |
| MTOR | regulates | gene | 0.95 |
| MTOR | regulates | protein | 0.95 |
| Circadian Rhythms | regulates | pathway | 0.90 |
| SIRT1 | regulates | protein | 0.90 |
| mTOR | modulates | pathway | 0.90 |
| mTOR | regulates | protein | 0.90 |
| Autophagy | regulates | process | 0.85 |
| RUBCN Deficiency | associated_with | phenotype | 0.85 |
| Ampk | regulates | pathway | 0.85 |
| Sex Hormones | regulates | compound | 0.85 |
| Mitochondrial-Derived Vesicles | regulates | mechanism | 0.85 |
| AMPK | regulates | protein | 0.85 |
| RUBCN | regulates | gene | 0.85 |
| Mitochondrial-Derived Vesicles | involved_in | organelle | 0.85 |
| Glycophagy | associated_with | process | 0.85 |
| LOXL3 | involved_in | gene | 0.82 |
| PI3K/AKT/mTOR | regulates | entity | 0.80 |
| PI3K | regulates | pathway | 0.80 |
| PER | regulates | gene | 0.80 |
| CRY | regulates | gene | 0.80 |
| BMAL1 | regulates | gene | 0.80 |
| TREM2 | regulates | protein | 0.80 |
| Stress Granules | interacts_with | process | 0.75 |
| RIPK1 | interacts_with | protein | 0.75 |
| Sex Chromosomes | modulates | biomarker | 0.75 |
| ELF3 | regulates | gene | 0.75 |
| PI3K_AKT_MTOR | regulates | pathway | 0.72 |
| RUBCN/Rubicon | regulates | gene | 0.70 |
| AMPK | regulates | protein | 0.70 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| CERS2 genetic deletion rescues IL-10 deficiency inflammation | validation | inflammatory bowel disease | 0.850 | 0.00 | IL-10/CERS2 double knockout mi | proposed | N/A |
| Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Validation: Membrane-Nucleation in iPSC Neurons | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,730,000 |
| Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $7,100,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| EMP1 safeguards hematopoietic stem cells by suppressing sphingolipid metabolism [PMID:40624017] | Li L, Lei Y, Li Y, Xie Y, Hui P, Zang X, | Nat Commun | 2025 | 1 |
| IL-10 constrains sphingolipid metabolism to limit inflammation. [PMID:38383790] | York AG, Skadow MH, Oh J, Qu R, Zhou QD, | Nature | 2024 | 1 |
| PAQR4 regulates adipocyte function and systemic metabolic health by mediating ce [PMID:38961186] | Zhu Q, Chen S, Funcke JB, Straub LG, Lin | Nat Metab | 2024 | 1 |
| Modulating LRP1 Pathways in Alzheimer's Disease: Mechanistic Insights and Emergi [PMID:41772271] | Mushtaq T, Hameed H, Khan MA, Tariq U, H | Molecular neurobiology | 2026 | 0 |
| Resibufogenin protects against atherosclerosis in ApoE(-/-) mice through blockin [PMID:40258472] | Xiaoyang C, Yijun C, Chenguang Z, Wanyin | J Adv Res | 2026 | 0 |
| High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence Fro [PMID:41406402] | Du Y, Borné Y, Samuelsson J, Glans I, Hu | Neurology | 2026 | 0 |
| Macrophage-Specific E3 Ubiquitin Ligase TRIM31 Reduces Atherosclerotic Plaque Fo [PMID:41410044] | Zhang J, Yu L, Yang W, Cao L, Wang X et | Circulation | 2026 | 0 |
| The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and [PMID:41527736] | Abedin MJ, Kastanenka KV | J Alzheimers Dis | 2026 | 0 |
| Opioid-induced transcriptional reprogramming of cerebrospinal fluid immune cells [PMID:41674808] | Acharya A, Ambikan AT, Neogi U, Lamberty | Res Sq | 2026 | 0 |
| Siah2 is a lipid-mediated metabolic sensor in adipose tissue macrophage. [PMID:41690475] | Dang TN, Ghosh B, Panta PR, Taylor JM, K | J Lipid Res | 2026 | 0 |
| Lipidome and proteome of astrocyte and microglia ApoE lipoprotein reveal differe [PMID:41692246] | Strickland MR, Wang Z, Golden LR, Wang H | J Lipid Res | 2026 | 0 |
| Microcephaly-associated protein WDR62 supports purine metabolism by interacting [PMID:41787126] | Morris MJ, Yeap YY, Edwards JR, Chen C, | EMBO J | 2026 | 0 |
| Sirtuin 1 mediated ceramide metabolism regulates intestinal mechanical barrier f [PMID:41856194] | Ma X, Liu Q, Mai K, Zhang Y | Int J Biol Macromol | 2026 | 0 |
| Nonvital Pulp Therapy in Primary Teeth Using Mineral Trioxide Aggregate Obturati [PMID:41928850] | Makiguchi T, Terauchi Y, Wong K, Bogen G | Case Rep Dent | 2026 | 0 |
| HTRA1 and Brain Disorders: A Balancing Act Across Neurodegeneration and Repair. [PMID:41932381] | Hjæresen S, Gramkow ET, Zhang M, Svennin | Prog Neurobiol | 2026 | 0 |
| Alzheimer's disease basics: we all should know. [PMID:40639927] | Das S | Neurological research | 2026 | 0 |
| Association of Periodontal Pathogens and Their Inflammatory Mediators With Alzhe [PMID:41890452] | Arriaga P, Vianna K, Montez C, Panariell | Cureus | 2026 | 0 |
| Genetic modifiers of APOE-ε4-associated cognitive decline. [PMID:41720779] | Contreras AG, Walters S, Eissman JM, Arc | Nature communications | 2026 | 0 |
| Protective ApoE variants support neuronal function by effluxing oxidized phospho [PMID:41338186] | Ralhan I, Do AD, Bae JY, Feringa FM, Cai | Neuron | 2026 | 0 |
| Metabolic abnormalities and reprogramming in cats with naturally occurring hyper [PMID:39499136] | ["Li Q", "Homilius M", "Achilles E", "Ma | ESC heart failure | 2025 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning METABOLISM in their description or question text
Score: 0.620 · neurodegeneration · 2026-04-21
## Mechanistic Overview Synaptic RNA Metabolism Dysregulation starts from the claim that modulating TARDBP within the di
Score: 0.612 · neurodegeneration · 2026-04-02
## Mechanistic Overview Restoring Neuroprotective Tryptophan Metabolism via Targeted Probiotic Engineering starts from t
Score: 0.610 · neurodegeneration · 2026-04-04
## Mechanistic Overview APOE4-Lipid Metabolism Correction starts from the claim that modulating APOE within the disease
Score: 0.530 · neuropharmacology · 2026-04-25
Covalent modulation of transporters or metabolic enzymes changes local receptor occupancy in a context-dependent manner.
Score: 0.525 · neurodegeneration · 2026-04-21
## Mechanistic Overview TREM2 Epigenetic Window for Microglial Lipid Metabolism starts from the claim that modulating TR
Score: 0.506 · neuroinflammation · 2026-04-21
## Mechanistic Overview PKM2 nuclear translocation bridges metabolism and inflammatory transcription in primed microglia
Score: 0.482 · neuroinflammation · 2026-04-21
## Mechanistic Overview SIRT3 gates microglial surveillance versus primed metabolism through mitochondrial deacetylation